Free Trial

Wedbush Reiterates "Outperform" Rating for National Health Investors (NYSE:NHI)

National Health Investors logo with Finance background
Remove Ads

Wedbush reissued their outperform rating on shares of National Health Investors (NYSE:NHI - Free Report) in a report published on Monday morning, Marketbeat Ratings reports. The brokerage currently has a $88.00 price objective on the real estate investment trust's stock. Wedbush also issued estimates for National Health Investors' Q1 2025 earnings at $1.11 EPS, Q2 2025 earnings at $1.16 EPS, Q3 2025 earnings at $1.18 EPS, Q4 2025 earnings at $1.21 EPS, Q1 2026 earnings at $1.20 EPS, Q2 2026 earnings at $1.21 EPS, Q3 2026 earnings at $1.22 EPS and Q4 2026 earnings at $1.23 EPS.

Separately, Truist Financial decreased their price target on shares of National Health Investors from $78.00 to $72.00 and set a "hold" rating for the company in a report on Monday, December 23rd. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $85.50.

Read Our Latest Research Report on NHI

National Health Investors Stock Down 1.7 %

Shares of NYSE NHI traded down $1.28 during trading hours on Monday, hitting $73.47. 712,093 shares of the stock were exchanged, compared to its average volume of 203,307. National Health Investors has a 12 month low of $57.80 and a 12 month high of $86.13. The firm has a fifty day moving average price of $70.22 and a 200-day moving average price of $74.68. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The company has a market cap of $3.36 billion, a PE ratio of 25.25, a PEG ratio of 4.42 and a beta of 1.08.

Remove Ads

National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings results on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.10 by $0.03. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business had revenue of $85.75 million for the quarter, compared to the consensus estimate of $81.13 million. On average, sell-side analysts expect that National Health Investors will post 4.41 EPS for the current year.

National Health Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 2nd. Investors of record on Monday, March 31st will be given a dividend of $0.90 per share. The ex-dividend date is Monday, March 31st. This represents a $3.60 dividend on an annualized basis and a yield of 4.90%. National Health Investors's dividend payout ratio is presently 115.38%.

Institutional Investors Weigh In On National Health Investors

Hedge funds have recently added to or reduced their stakes in the business. Quarry LP purchased a new stake in shares of National Health Investors in the third quarter worth about $27,000. Point72 DIFC Ltd acquired a new position in National Health Investors in the third quarter valued at approximately $35,000. Loomis Sayles & Co. L P purchased a new stake in National Health Investors in the 3rd quarter worth approximately $38,000. Assetmark Inc. grew its stake in shares of National Health Investors by 27.8% during the 3rd quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust's stock worth $54,000 after purchasing an additional 141 shares during the period. Finally, GF Fund Management CO. LTD. purchased a new position in shares of National Health Investors during the 4th quarter valued at approximately $58,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Company Profile

(Get Free Report)

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Recommended Stories

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads